Genetic Basis of Ventricular Arrhythmias

Current Cardiovascular Risk Reports

Volumn 4, Issue 6, 2010, Pages 454-460

  Pazoki, Raha ^a,b   Wilde, Arthur A M ^a   Bezzina, Connie R ^a,b  

^a Heart Failure Research Center   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac arrhythmias; Genetic polymorphisms; Genetics; Genome wide association study; Mutation; Sudden cardiac death; Ventricular fibrillation

Indexed keywords

EID: 84873526353     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-010-0128-2     Document Type: Review

References (59)

1. Myerburg RJ, Castellanos A: Cardiac arrest and sudden cardiac death. In Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 8th edn. Edited by Libby P, Bonow RO, Mann DL, Zipes DP. Oxford: Elsevier; 2007.
2. Huikuri HV, Castellanos A, Myerburg RJ: Sudden death due to cardiac arrhythmias. N Engl J Med 2001, 345: 1473-1482.
3. Liberthson RR: Sudden death from cardiac causes in children and young adults. N Engl J Med 1996, 334: 1039-1044.
4. van der Werf C, Hofman N, Tan HL, et al.: The diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in the Netherlands. Heart Rhythm 2009; doi: 10. 1016/j. hrthm. 2010. 05. 03.
5. Corrado D, Basso C, Thiene G: Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res 2001, 50: 399-408.
6. Drory Y, Turetz Y, Hiss Y, et al.: Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 1991, 68: 1388-1392.
7. Tan HL, Hofman N, van Langen IM, et al.: Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 2005, 112: 207-213.
8. Basso C, Carturan E, Pilichou K, et al.: Sudden cardiac death with normal heart molecular autopsy. Cardiovasc Pathol 2010 (in press).
9. Zipes DP, Wellens HJ: Sudden cardiac death. Circulation 1998, 98: 2334-2351.
10. Friedlander Y, Siscovick DS, Weinmann S, et al.: Family history as a risk factor for primary cardiac arrest. Circulation 1998, 97: 155-160.
11. Jouven X, Desnos M, Guerot C, Ducimetiere P: Predicting sudden death in the population: the Paris Prospective Study I. Circulation 1999, 99: 1978-1983.
12. Dekker LR, Bezzina CR, Henriques JP, et al.: Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients. Circulation 2006, 114: 1140-1145.
13. Wilde AA, Bezzina CR: Genetics of cardiac arrhythmias. Heart 2005, 91: 1352-1358.
14. Schwartz PJ, Priori SG, Spazzolini C, et al.: Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001, 103: 89-95.
15. Priori SG, Napolitano C, Schwartz PJ, et al.: Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 2004, 292: 1341-1344.
16. • Hofman N, Tan HL, Alders M, et al.: Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment? J Am Coll Cardiol 2010, 55: 2570-2576. This retrospective study investigated the follow-up and treatment of mutation-positive relatives of probands with an inherited arrhythmia syndrome who were identified by active cascade screening in these families. This study showed that active cascade screening in families with LQTS, Brugada syndrome, and catecholamine-induced polymorphic ventricular tachycardia (CPVT) resulted in immediate prophylactic treatment in a substantial proportion of mutation carriers, particularly in LQTS and CPVT.
17. • Kapa S, Tester DJ, Salisbury BA, et al.: Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. Circulation 2009, 120: 1752-1760. This study, which was carried out in 388 unrelated "definite" cases of LQTS and more than 1300 healthy controls, sought to quantify the value of mutation type and gene/protein region in determining the probability of pathogenicity for mutations in the most commonly affected LQTS genes (KCNQ1 [LQT1], KCNH2 [LQT2], and SCN5A [LQT3]).
18. Priori SG, Napolitano C, Schwartz PJ: Low penetrance in the long-QT syndrome: clinical impact. Circulation 1999, 99: 529-533.
19. Scicluna BP, Wilde AA, Bezzina CR: The primary arrhythmia syndromes: same mutation, different manifestations. Are we starting to understand why? J Cardiovasc Electrophysiol 2008, 19: 445-452.
20. Survivors of out-of-hospital cardiac arrest with apparently normal heart. Need for definition and standardized clinical evaluation. Consensus Statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States. Circulation 1997, 95: 265-272.
21. •• Alders M, Koopmann TT, Christiaans I, et al.: Haplotype-sharing analysis implicates chromosome 7q36 harboring DPP6 in familial idiopathic ventricular fibrillation. Am J Hum Genet 2009, 84: 468-476. In this study, haplotype-sharing analysis in three distantly related families identified an ancestral haplotype, including the DPP6 gene, that was shared among cases affected with idiopathic VF, implicating this gene in this disorder.
22. Radicke S, Cotella D, Graf EM, et al.: Expression and function of dipeptidyl-aminopeptidase-like protein 6 as a putative beta-subunit of human cardiac transient outward current encoded by Kv4. 3. J Physiol 2005, 565: 751-756.
23. Wasserburger RH, Alt WJ.: The normal RS-T segment elevation variant. Am J Cardiol 1961, 8: 184-192.
24. •• Haissaguerre M, Derval N, Sacher F, et al.: Sudden cardiac arrest associated with early repolarization. N Engl J Med 2008, 358: 2016-2023. This study reviewed data from 206 cases who were resuscitated after cardiac arrest due to idiopathic VF and assessed the prevalence of electrocardiographic early repolarization. A group of 412 individuals without heart disease who were matched for age, sex, race, and level of physical activity were used as controls. This study showed that there is an increased prevalence of early repolarization among patients with a history of idiopathic VF.
25. •• Nam GB, Kim YH, Antzelevitch C: Augmentation of J waves and electrical storms in patients with early repolarization. N Engl J Med 2008, 358: 2078-2079. This case-control study evaluated the incidence of early repolarization among 1395 controls who were representative of the general population and 15 patients classified as having idiopathic VF. An increased incidence of early repolarization was found in the latter group.
26. Rosso R, Kogan E, Belhassen B, et al.: J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. J Am Coll Cardiol 2008, 52: 1231-1238.
27. Tikkanen JT, Anttonen O, Junttila MJ, et al.: Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med 2009, 361: 2529-2537.
28. Haissaguerre M, Chatel S, Sacher F, et al.: Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel. J Cardiovasc Electrophysiol 2009, 20: 93-98.
29. Zipes DP, Camm AJ, Borggrefe M, et al.: ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006, 114: e385-e484.
30. Myerburg RJ: Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol 2001, 12: 369-381.
31. Arking DE, Chugh SS, Chakravarti A, Spooner PM: Genomics in sudden cardiac death. Circ Res 2004, 94: 712-723.
32. Myerburg RJ, Castellanos A: Emerging paradigms of the epidemiology and demographics of sudden cardiac arrest. Heart Rhythm 2006, 3: 235-239.
33. Noseworthy PA, Newton-Cheh C: Genetic determinants of sudden cardiac death. Circulation 2008, 118: 1854-1863.
34. Bezzina CR, Pazoki R, Bardai A, et al.: Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction. Nat Genet 2010 (in press). This is the first case-control genome-wide association study carried out in patients with a first acute MI aimed at identifying common genetic variants associated with VF during acute ischemia. This study uncovered SNPs at the CXADR locus associated with VF.
35. Bowles NE, Richardson PJ, Olsen EG, Archard LC: Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986, 1: 1120-1123.
36. Pauschinger M, Bowles NE, Fuentes-Garcia FJ, et al.: Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 1999, 99: 1348-1354.
37. Andreoletti L, Venteo L, Douche-Aourik F, et al.: Active Coxsackie viral B infection is associated with disruption of dystrophin in endomyocardial tissue of patients who died suddenly of acute myocardial infarction. J Am Coll Cardiol 2007, 50: 2207-2214.
38. • Lisewski U, Shi Y, Wrackmeyer U, et al.: The tight junction protein CAR regulates cardiac conduction and cell-cell communication. J Exp Med 2008, 205: 2369-2379. Through studies in inducible Coxsackievirus and adenovirus receptor (CAR) knockout mice, these investigators reported a physiologic role for CAR in atrioventricular conduction. This study also showed that loss of CAR was accompanied by downregulation of connexin45 and connexin43 at the intercalated disk.
39. • Lim BK, Xiong D, Dorner A, et al.: Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart. J Clin Invest 2008, 118: 2758-2770. This study reported a role for the Coxsackievirus and adenovirus receptor (CAR) in atrioventricular conduction through studies in cardiac-specific CAR knockout mice and global CAR knockout embryonic hearts. This study also demonstrated that localization of connexin 45 at the AV-node cell-cell junction and of β-catenin and ZO-1 at the ventricular intercalated disc are dependent on CAR.
40. Havlik RJ, Garrison RJ, Fabsitz R, Feinleib M: Variability of heart rate, P-R, QRS and Q-T durations in twins. J Electrocardiol 1980, 13: 45-48.
41. Busjahn A, Knoblauch H, Faulhaber HD, et al.: QT interval is linked to 2 long-QT syndrome loci in normal subjects. Circulation 1999, 99: 3161-3164.
42. Schouten EG, Dekker JM, Meppelink P, et al.: QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991, 84: 1516-1523.
43. Straus SM, Kors JA, De Bruin ML, et al.: Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 2006, 47: 362-367.
44. Vrtovec B, Delgado R, Zewail A, et al.: Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation 2003, 107: 1764-1769.
45. Arking DE, Pfeufer A, Post W, et al.: A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 2006, 38: 644-651.
46. • Newton-Cheh C, Eijgelsheim M, Rice KM, et al.: Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet 2009, 41: 399-406. This meta-analysis of three genome-wide association studies in individuals of European ancestry uncovered multiple novel common genetic variants associated with QT interval in general population.
47. • Pfeufer A, Sanna S, Arking DE, et al.: Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet 2009, 41: 407-414. This report analyzed genome-wide data from five population-based cohorts in individuals of European ancestry and identified multiple novel loci associated with the QT interval.
48. • Crotti L, Monti MC, Insolia R, et al.: NOS1AP is a genetic modifier of the long-QT syndrome. Circulation 2009, 120: 1657-1663. This family-based association study carried out in LQTS families segregating the KCNQ1 A341V founder mutation (205 mutation carriers, 228 non-carriers), demonstrated for the first time that NOS1AP SNPs modify disease expression (QT interval and arrhythmia risk) in this disorder.
49. • Tomás M, Napolitano C, De GL, et al.: Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome. J Am Coll Cardiol 2010, 55: 2745-2752. This cohort study carried out 901 patients from 520 families with LQTS caused by mutations in different genes provided evidence for a role of SNPs in the NOS1AP gene in modulation of QT interval duration and risk of arrhythmias in this disorder.
50. Kao WH, Arking DE, Post W, et al.: Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations. Circulation 2009, 119: 940-951.
51. • Holm H, Gudbjartsson DF, Arnar DO, et al.: Several common variants modulate heart rate, PR interval and QRS duration. Nat Genet 2010, 42: 117-122. This report entailed a genome-wide association study in individuals of European descent that uncovered multiple common genetic variants associated with heart rate and ECG indices of conduction (PR- and QRS-interval).
52. • Chambers JC, Zhao J, Terracciano CM, et al.: Genetic variation in SCN10A influences cardiac conduction. Nat Genet 2010, 42: 149-152. This report entailed a genome-wide association study in Asians and Europeans that identified SNPs in SCN10A modulating cardiac conduction.
53. • Pfeufer A, van NC, Marciante KD, et al.: Genome-wide association study of PR interval. Nat Genet 2010, 42: 153-159. This report entailed a meta-analysis of genome-wide association studies for PR interval from multiple population-based European studies that revealed multiple common genetic variants associated with this trait.
54. Schott JJ, Alshinawi C, Kyndt F, et al.: Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 1999, 23: 20-21.
55. Jay PY, Harris BS, Buerger A, et al.: Function follows form: cardiac conduction system defects in Nkx2-5 mutation. Anat Rec A Discov Mol Cell Evol Biol 2004, 280: 966-972.
56. Moskowitz IP, Kim JB, Moore ML, et al.: A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell 2007, 129: 1365-1376.
57. Mesbah K, Harrelson Z, Theveniau-Ruissy M, et al.: Tbx3 is required for outflow tract development. Circ Res 2008, 103: 743-750.
58. Postma AV, van de Meerakker JB, Mathijssen IB, et al.: A gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation. Circ Res 2008, 102: 1433-1442.
59. Schinzel A: Ulnar-mammary syndrome. J Med Genet 1987, 24: 778-781.